Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020

Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020

  • March 2021 •
  • 58 pages •
  • Report ID: 6066617 •
  • Format: PDF
Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020

Summary
The purpose of this report is to provide insight into the clinical trial landscape for 2020, an analyses of the main features of these trials, and quarterly trends, where relevant.

This report provides an overview of global clinical trials with a start date between January 1, 2020 and December 31, 2020. Due to the COVID-19 pandemic, many of these trials have either been interrupted or disrupted.

Scope
- The clinical trials data used for these analyses were extracted from Clinical Trials Database. The data included clinical trials with a start date between January 1, 2020 to December 31, 2020, which were captured in the database as of February 13, 2021.
- The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials.
- Additional analyses were conducted for trials that were completed or terminated, as well as COVID-19 trials in all recruitment statuses. COVID-19 was the top indication for clinical trials at the time when the data were locked for analysis.

Reasons to Buy
- Understand the global clinical trial landscape in 2020
- The trends of completed clinical trials in 2020
- The trends of clinical trial terminations in 2020
- A closer look at COVID-19 clinical trials in 2020
- Understand the changes in 2020 and the impact for 2021
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.